Cargando…
P1142: AFM13 IN PATIENTS WITH R/R PERIPHERAL T CELL LYMPHOMA (PTCL): A POST-HOC SUBGROUP ANALYSIS FROM THE REDIRECT STUDY
Autores principales: | Kim, Won-Seog, Shortt, Jake, Luigi Zinzani, Pier, Mikhaylova, Natalya, Marin-Niebla, Ana, Radeski, Dejan, Ribrag, Vincent, Domingo Domènech, Eva, Sawas, Ahmed, Alexis, Karenza, Emig, Michael, Garcia, Linta, Overesch, Andre, Pietzko, Kerstin, Horwitz, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431079/ http://dx.doi.org/10.1097/01.HS9.0000971464.68430.62 |
Ejemplares similares
-
PB2358: PHASE 1-2 STUDY OF THE SAFETY, PK, PD, AND PRELIMINARY ACTIVITY OF TOLINAPANT IN COMBINATION WITH ORAL DECITABINE/CEDAZURIDINE AND ORAL DECITABINE/CEDAZURIDINE ALONE IN SUBJECTS WITH R/R PTCL
por: Shortt, Jake, et al.
Publicado: (2023) -
Vacuum Stability in Test Section 333, (R 1142, 17th July 1980)
por: Mathewson, A, et al.
Publicado: (1980) -
P1141: ENCOURAGING COMPLETE RESPONSES (CRS) OBSERVED WITH CDK9 INHIBITOR AZD4573 IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL): EARLY TRIAL ANALYSIS
por: Shortt, Jake, et al.
Publicado: (2023) -
PB1884: ENGAGING INNATE IMMUNITY: A PHASE 1 DOSE ESCALATION STUDY TO ASSESS SAFETY AND TOLERABILITY OF AFM28 MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CD123-POSITIVE ACUTE MYELOID LEUKEMIA (AML)
por: Arnan, Montserrat, et al.
Publicado: (2023) -
Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group
por: Aubrais, Raphaelle, et al.
Publicado: (2022)